Tenex Health Reaches 100 Center Milestone in Adoption of Novel Percutaneous Tenotomy Technology

LAKE FOREST, Calif.--(BUSINESS WIRE)--Tenex Health is proud to announce that since the commercial launch of the TX1 System in February of 2012, over 100 medical centers throughout the United States have successfully used the company’s new technology to treat patients with tendon injuries. Since that time, physicians at these centers have treated over 1400 patients who suffer from pain related to tendon injuries affecting the shoulder, elbow, knee, foot and ankle. The novel technology is designed to specifically cut and remove damaged tendon tissue while leaving healthy tissue unaffected. This provides for a safe and well-tolerated experience for the patient as the entire intervention is conducted under local anesthesia.

“The percutaneous tenotomy technique developed by Tenex provides a safe and precise means of targeting the lesion and delivers the ability to cut and debride the unhealthy tissue and to create an environment for new and healthier tissue to grow.”

Dr. Kris Stowers, staff physician at Tallahassee Orthopedic Clinic in Florida and team physician for the Florida State University Football Team commented, “The technology pioneered by Tenex to address tendon related injuries offers us an ability to treat the patients earlier and for which currently there is not a very good solution. In my experience the patients have tolerated the treatment very well and I have been impressed with the results and rapid recovery time. The safe attributes of the technology also provides me an opportunity to treat a wide range of patients, from well-conditioned athletes to senior citizens.”

“I have treated over 50 patients with this novel technology who were presented with joint pain related to over-use tendon injury affecting the elbow, knee, Achilles and plantar fascia,” stated Dr Josh Hackel, Director of Primary Care Sports Medicine at the Andrews Institute in Gulf Breeze, FL. “What excites me about this compelling technology is the ability to deliver a meaningful solution earlier in the patient’s course of disease instead of only offering a cortisone injection which may actually be harmful to the tendon and negatively affect the patients healing process.”

Dr. Michel Kelly, a sports medicine physician practicing at Specialty Surgical Center in Sparta, NJ and ringside physician for professional boxing and professional mixed martial arts commented, “The percutaneous tenotomy technique developed by Tenex provides a safe and precise means of targeting the lesion and delivers the ability to cut and debride the unhealthy tissue and to create an environment for new and healthier tissue to grow.”

About Tenex Health, Inc.

Tenex Health, Inc. (www.tenexhealth.com) develops and markets innovative therapies for the treatment of tendon pain due to trauma or repetitive motion injuries. The minimally invasive technique, known as FAST™ (Fasciotomy and Surgical Tenotomy), utilizes the company’s proprietary TX1™ Tissue Removal System to cut, debride and remove diseased tissue in an out-patient setting using only a local anesthetic (www.fastprocedure.com). Since the surrounding healthy tendon tissue is not disturbed, patients enjoy less discomfort and faster recovery times versus traditional open surgical procedures.